Technical Analysis – US 30 index resumes bullish bias; upside risks improve



The US30 stock index (Cash) has currently crept over the all-time high of 33,253 and is headed for the 33,638 level, which happens to be the 261.8% Fibonacci extension of the down leg from 28,900 to 26,065. The sturdy advancing simple moving averages (SMA) are defending the bullish structure, while positive sentiment appears to be picking up.

The Ichimoku lines are conveying the above mentioned view point - as are the short-term oscillators - and are starting to turn upwards after a flattened state. The MACD, in the positive region, is holding above its horizontal red trigger line, while the RSI is rising towards the 70 level. The stochastic oscillator resides in overbought territory and it appears that the %K line is starting to recover.

To the upside, resistance could originate from the 261.8% Fibo extension of 33,638. If buying interest persists, and the price overcomes this barrier, the 34,000 handle and the 34,500 boundary respectively could then provide the next constraints impeding further appreciation.

If sellers retake control and steer the price down, downside friction could arise from the red Tenkan-sen line at 32,740 ahead of the critical support section of 31,669-32,149, reinforced by the blue Kijun-sen line and the 50-day SMA. A more profound retraction in the index could then challenge the Ichimoku cloud and the 100-day SMA around 31,056 before the trough at 30,542 steps into the picture.

Summarizing, the index is sustaining a bullish bias above the 31,669-32,149 support base, the SMAs and the cloud. A break below 30,542 could highlight negative price tendencies.

Latest News


Technical Analysis – Netflix stock holds trendless below July’s peaks ahead of earnings


Netflix earnings eyed amid declining market share; focus on subscribers – Stock Market News


Technical Analysis – US 500 index ready to elevate all-time high


Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.